Vaccine-Specific Recommendations (by Date Published)
Advisory Committee for Immunization Practices (ACIP)
Consult the ACIP Recommendations page for a complete list of Morbidity and Mortality Weekly Reports (MMWR) on Recommendations of the Advisory Committee on Immunization Practices (ACIP) related to vaccines and immunizations.
Links to final CDC vaccination recommendations (published in MMWR) from Advisory Committee on Immunization Practices (ACIP)
Listed by Date Published
Meningococcal Vaccine Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016 Source: MMWR . 2017;66(19);509-13. Oral Cholera vaccine Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine Source: MMWR . 2017;66(18);482-5. Adult immunization schedule Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017 Source: MMWR . 2017;66(5);136-8. Child/adolescent immunization schedule Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2017 Source: MMWR . 2017;66(5);134-5.
Human Papillomavirus vaccination Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices Source: MMWR . 2016;65(49);1405-8. Meningococcal conjugate vaccine Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016 Source: MMWR . 2016;65(43);1189-94. Influenza vaccines (2016-17 season) Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2016–17 Influenza Season Source: MMWR . 2016;65(5);1-54. Smallpox vaccine Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses — Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015 Source: MMWR . 2016;65(10);257-262. Child/adolescent immunization schedules Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2016 Source: MMWR . 2016;65(4);88-90. Adult immunization schedule Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2016 Source: MMWR . 2016;65(4);86-87.
Meningococcal vaccine MacNeil JR , Rubin L , Folaranmi T , Ortega-Sanchez IR, Patel M , Martin SW . Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults Source: MMWR . 2015:64(41);1171-6 DTaP vaccine Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose Source: MMWR . 2015:64(34);948-949 Influenza vaccines (2015-16 season) Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP – U.S., 2015-16 Influenza Season Source: MMWR . 2015:64(30);818-825 PCV13 and PPSV23 vaccines Intervals between PCV13 and PPSV23 vaccines: recommendations of the ACIP Source: MMWR . 2015;64(34):944-7 Yellow Fever vaccine Use of Yellow Fever Vaccine Booster Doses Source: MMWR . 2015;64(23);647-650 Serogroup B Meningococcal vaccine Use of Serogroup B Meningococcal Vaccines in Persons Aged =10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the ACIP, 2015 Source: MMWR . 2015;64(22);608-612 Typhoid vaccine Updated Recommendations for the Use of Typhoid Vaccine Source: MMWR . 2015;64(11);305-308 HPV vaccine Use of 9-Valent Human Papillomavirus (HPV) Vaccine Source: MMWR . 2015;64(11);300-304 Child/adolescent immunization schedules ACIP Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2015 Source: MMWR . 2015;64(04);93-94 Adult immunization schedule ACIP Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2015 Source: MMWR . 2015;64(04);91-92
Top of Page
Pneumococcal vaccines Use of PCV-13 and PPSV-23 vaccine among adults aged 65 and older: recommendations of the ACIP Source: MMWR . 2014;63(37);822-825 HPV vaccine Human Papillomavirus Vaccination: Recommendations of the ACIP Source: MMWR ; August 29, 2014 / 63(RR05);1-30 Influenza vaccines (2014-15 season) Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the ACIP – U.S., 2014-15 Influenza Season Source: MMWR ; August 15, 2014 / 63(32);691-697 Meningococcal vaccine Use of MenACWY-CRM Vaccine in Children Age 2 Through 23 Months at Increased Risk, Recommendations of the ACIP, 2013 Source: MMWR ; June 20, 2014 / 63(24);527-530 Hib vaccine recommendations Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the ACIP, 2014 Source: MMWR ; February 28, 2014 / 63(RR01);1-14
Top of Page
JE vaccine for children Use of Japanese Encephalitis Vaccine in Children: Recommendations of the ACIP, 2013 Source: MMWR ; November 15, 2013 / 62(45);898-900 Influenza vaccines (2013-14 season) Source: MMWR ; September 20, 2013 / 62(RR07);1-43 Updated recommendations for use of VariZIG Updated Recommendations for Use of VariZIG—United States, 2013 Source: MMWR ; July 19, 2013 / 62(28);574-576 PCV13 and PPSV23 for ages 6-18 years with immuno. conditions Use of PCV-13 and PPSV-23 Vaccines Among Children Aged 6–18 Years with Immunocompromising Conditions Source: MMWR ; June 28, 2013 / 62(25);521-524 MMR and CRS Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 Summary: Recommendations of the ACIP Source: MMWR ; June 14, 2013 / 62(RR04);1-34 Influenza interim recommendations Source: MMWR ; May 10, 2013 / 62(18);356-356 Meningococcal disease Prevention and Control of Meningococcal Diseases: Recommendations of ACIP Source: MMWR ; March 22, 2013 / 62(RR02);1-22 Tdap and pregnancy Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women—ACIP, 2012 Source: MMWR ; February 22, 2013 / 62(07);131-135 Infant meningococcal vaccination Infant Meningococcal Vaccination: ACIP Recommendations and Rationale Source: MMWR ; January 25, 2013 / 62(03);52-54
PCV13 and PPSV23 for adults with immunocompromising conditions Use of PCV13 and PPSV23 Vaccine for Adults with Immunocompromising Conditions Source: MMWR ; October 12, 2012 / 61(40);816-819 Influenza vaccines (2012-13 season) Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP—United States, 2012–13 Influenza Season Source: MMWR ; August 17, 2012 / 61(32);613-618 Tdap for adults age 65 and older Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older, ACIP 2012 Source: MMWR ; June 28, 2012 / 61(25);468-470 Licensure of PCV13 for adults age 50 and older Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older Source: MMWR ; June 1, 2012 / 61(21);394-395 New framework (GRADE) for development of evidence-based recommendations Source: MMWR ; May 11, 2012 / 61(18);327-327 VariZIG for postexposure prophylaxis of varicella FDA Approval of an Extended Period for Administering VariZIG for Postexposure Prophylaxis of Varicella Source: MMWR ; March 30, 2012 / 61(12);212-212
Top of Page
Hepatitis B vaccine in adults with diabetes Policy Note: Use of Hepatitis B Vaccine in Adults with Diabetes Mellitus Source: MMWR ; December 23, 2011 / 60(50);1709-11 Use of HPV4 in males Policy Note: Recommendations on Use of Quadrivalent HPV in Males—ACIP, 2011 MMWR ; December 23, 2011 / 60(50);1705-8Health care personnel immunization Immunization of Health-Care Personnel: Recommendations of ACIP Source: MMWR ; November 25, 2011 / 60(RR07);1-45 Herpes Zoster vaccine (Shingles) Update on Herpes Zoster Vaccine: Licensure for Persons Aged 50 Through 59 Years Source: MMWR ; November 11, 2011 / 60(44);1528-1528 Tdap and Td vaccines and pregnancy Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months—ACIP, 2011 Source: MMWR ; October 21, 2011 / 60(41);1424-1426 Intussusception and rotavirus vaccineAddition of History of Intussusception as a Contraindication for Rotavirus Vaccination Source: MMWR ; October 21, 2011 / 60(41);1427-1427 Supplemental Meningococcal Recommendation of the ACIP for Use of MenACWY-D Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease Source: MMWR ; October 14, 2011 / 60(40);1391-1392 Influenza vaccines (2011-12 season) Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP, 2011 Source: MMWR ; August 26, 2011 / 60(33);1128-1132 Meningococcal conjugate vaccine Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease—ACIP, 2011 Source: MMWR ; August 5, 2011 / 60(30);1391-1392 Booster dose of JE vaccine Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine—ACIP, 2011 Source: MMWR ; May 27, 2011 / 60(20);661-663 JE vaccine for children Update on Japanese Encephalitis Vaccine for Children—United States, May 2011 Source: MMWR ; May 27, 2011 / 60(20);664-665 General recommendations Source: MMWR ; January 28, 2011 / 60(RR02);1-60 Meningococcal Conjugate vaccine Updated Recommendations for Use of Meningococcal Conjugate Vaccines—ACIP, 2010 Source: MMWR ; January 28, 2011 / 60(03);72-76 Influenza (Antiviral) Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza: Recommendations of ACIP Source: MMWR ; January 21, 2011 / 60(RR01);1-24 Tdap vaccine Updated Recommendations for the Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Accellular Pertussis (Tdap) Vaccine from the ACIP, 2010 Source: MMWR ; January 14, 2011 / 60(01);13-15
Top of Page
Pneumococcal (PCV13 and PPSV23) vaccine (infants & children) Prevention of Pneumococcal Disease Among Infants and Children—Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Source: MMWR ; December 10, 2010 / 59(RR11);1-18 Pneumococcal (PPSV23) vaccine (adults) Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using PPSV23 Source: MMWR ; September 3, 2010 / 59(34);1102-1106 Afluria influenza vaccine (2010-2011 season) Update: Recommendations of ACIP Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010-11 Source: MMWR ; August 13, 2010 /59(31);989-992 Influenza (and H1N1) vaccine Prevention and Control of Influenza with Vaccines Source: MMWR ; August 6, 2010 /59(RR08);1-62 Yellow Fever vaccine Yellow Fever Vaccine: Recommendations of the ACIP Source: MMWR ; July 30, 2010 / 59(RR07);1-27 Anthrax vaccine Use of Anthrax Vaccine in the United States Source: MMWR ; July 23, 2010 / 59(RR06);1-30 Human Papillomavirus (HPV2 and HPV4) vaccine
Measles, Mumps, Rubella and Varicella (MMRV) vaccine Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine Recommendations of the ACIP Source: MMWR ; May 7, 2010 / 59(RR03);1-12 Influenza vaccine (Fluzone high-dose) Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged =65 Years (Fluzone High-Dose) and Guidance for Use—United States, 2010 Source: MMWR ; April 30, 2010 / 59(16);485-486 Rabies vaccine Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies Recommendations of the ACIP Source: MMWR ; March 19, 2010 / 59(RR02);1-9 Meningococcal Conjugate vaccine (Menveo) Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use—ACIP, 2010 Source: MMWR ; March 12, 2010 / 59(09);273 13-Valent Pneumococcal Conjugate vaccine (PCV13) Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children—ACIP, 2010 Source: MMWR ; March 12, 2010 / 59(09);258-261 Japanese Encephalitis vaccines Japanese Encephalitis Vaccines Recommendations of the ACIP Source: MMWR ; March 12, 2010 / 59(RR01);1-27
Top of Page
Top of Page
Top of Page
Top of Page
